Compumedics Limited (ASX:CMP)

Compumedics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	2	2.69	1.89	3.8	7.29	6.77
Cash & Short-Term Investments	2	2.69	1.89	3.8	7.29	6.77
Cash Growth	-25.50%	42.33%	-50.22%	-47.94%	7.74%	5.58%
Accounts Receivable	15.55	14.88	10.43	12.53	14.13	13.01
Other Receivables	-	2.99	0.71	2.5	2.42	2.47
Receivables	15.55	17.87	11.14	15.03	16.54	15.49
Inventory	13.58	14.66	13.21	10.69	9.71	9.68
Total Current Assets	33.05	35.22	26.24	29.52	33.55	31.93
Property, Plant & Equipment	2.21	1.78	2.95	3.62	1.21	1.71
Long-Term Investments	0.7	0.76	0.65	0.7	-	-
Long-Term Deferred Tax Assets	-	-	0.35	1.1	0.5	0.82
Long-Term Deferred Charges	18.23	16.59	10.16	6.24	6.45	4.08
Total Assets	54.18	54.34	40.36	41.18	41.71	38.55

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	9.78	8.64	4.37	5.26	4.74	4.45
Accrued Expenses	3.86	4.28	3.93	3.71	3.51	3.15
Short-Term Debt	12.08	13.17	6.98	7.23	6.01	4.4
Current Portion of Leases	0.68	0.53	0.78	0.68	0.16	0.67
Current Income Taxes Payable	0.28	0.18	-	0.09	-	-
Current Unearned Revenue	1.63	1.53	1.34	2.69	1.92	1.75
Other Current Liabilities	0.47	3.52	3.86	1.54	1.2	0.94
Total Current Liabilities	28.77	31.85	21.25	21.19	17.54	15.35
Long-Term Debt	-	-	-	0.21	0.38	0.59
Long-Term Leases	0.64	0.18	0.83	1.36	-	0.16
Long-Term Unearned Revenue	0.18	0.24	0.03	0.08	0.15	0.27
Pension & Post-Retirement Benefits	0.04	0.03	0.04	0.07	0.05	0.02
Long-Term Deferred Tax Liabilities	1.18	0.33	-	-	-	-
Total Liabilities	30.81	32.63	22.15	22.89	18.12	16.39

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	41.41	39.45	35.65	35.65	35.65	35.65
Retained Earnings	-18.31	-18.58	-17.31	-17.79	-11.67	-13.03
Comprehensive Income & Other	0.28	0.84	-0.13	0.43	-0.39	-0.47
Shareholders' Equity	23.37	21.71	18.21	18.29	23.59	22.16
Total Liabilities & Equity	54.18	54.34	40.36	41.18	41.71	38.55

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Debt	13.4	13.88	8.58	9.47	6.55	5.82
Net Cash (Debt)	-11.39	-11.19	-6.69	-5.67	0.75	0.95
Net Cash Growth	-	-	-	-	-21.47%	-41.10%
Net Cash Per Share	-0.05	-0.06	-0.04	-0.03	0.00	0.01
Filing Date Shares Outstanding	199.76	192.22	183.77	177.16	177.16	177.16
Total Common Shares Outstanding	199.76	192.22	177.16	177.16	177.16	177.16
Working Capital	4.28	3.37	4.99	8.33	16.01	16.58
Book Value Per Share	0.12	0.11	0.10	0.10	0.13	0.13
Tangible Book Value	23.37	21.71	18.21	18.29	23.59	22.16
Tangible Book Value Per Share	0.12	0.11	0.10	0.10	0.13	0.13
Machinery	-	10.82	10.61	10.36	9.94	9.33
Leasehold Improvements	-	1.08	1.13	1.07	0.61	0.61

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 7, 2026

Data Sources Report a data error